Committee of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association; Chinese College of Interventionalists; Expert Committee on Interventional Therapy, Chinese Society of finical Onco...
Committee of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association; Chinese College of Interventionalists; Expert Committee on Interventional Therapy, Chinese Society of Clinical Onc...
GUAN Haitao, FAN Zeyang, WANG Jian, TONG Xiaoqiang, ZOU Yinghua*(Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing 100034, China)[Abstract] Objecti...
Committee of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association; Chinese College of Interventionalists; Expert Committee on Interventional Therapy, Chinese Society of Clinical Onc...
Committee of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association; Chinese College of Interventionalist; Expert Committee on Interventional Therapy, Chinese Society of Clinical Onco...
CAO Xiao-Meng1, GAO Song2, ZHU Xu2, WANG Mei2, ZHANG Hong-Zhi2, CHENG Xue-Hui1*【Abstract】Objective We aimed to evaluate the technology of the new generation of domestic co-ablation system and provid...
(1. School of Medicine Tsinghua University, Beijing 100084, China; 2. Department of Dermatology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China)CLC No.: R616.3Documen...
GUAN Haitao1, LI Tiantian2, FAN Zeyang1, WANG Jian1, ZOU Yinghua1*(1. Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing 100034, China; 2. Departmen...
QIAN Zhuyin1*, YU Jianhe2, CHENG Zhi3, CHEN Yiqiu4, ZHU Yichao41Pancreas Center, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210003;2Department of Medical Oncology, Xinghua C...
QIAN Zhuyin1*, ZHANG Bin1, CHEN Yiqiu2, WU Yingchun3, GU Yuqing1, ZHU Yichao21Pancreas Center, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210003; 2Department of Physiology, ...
Shuo Yang, et al[Abstract]Treatment strategies for advanced non–small cell lung cancer (NSCLC) patients who develop oligo-residual disease (ORD) after responding to immunotherapy remain undefined. Th...
EN 
